Challenges in neoantigen-directed therapeutics
Cancer Cell, vol. 41, pp. 15–40
Authors 13
-
Affiliation as printed
myNEO NV, 9000 Ghent, Belgium
-
Affiliation as printed
myNEO NV, 9000 Ghent, Belgium
-
Affiliation as printed
myNEO NV, 9000 Ghent, Belgium
-
Affiliation as printed
Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium
-
Affiliation as printed
Department of Pharmaceutics, Ghent University, 9000 Ghent, Belgium
-
Affiliation as printed
Laboratory of Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium
-
Affiliation as printed
Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
-
Stanford Medicine · Stanford University
Affiliation as printed
Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA, USA
-
Affiliation as printed
Department of Data Analysis and Mathematical Modelling, Ghent University, Ghent, Belgium
-
Affiliation as printed
Laboratory of Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium
-
Leiden University Medical Center
Affiliation as printed
Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands
-
Harvard University · Dana-Farber Cancer Institute
Affiliation as printed
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
-
Cedric Bogaert corresponding
Affiliation as printed
myNEO NV, 9000 Ghent, Belgium. Electronic address: cedric@myneo.me
myNEO NV, 9000 Ghent, Belgium
Cited by 143 stored of 143
Cited by patents worldwide 1 (Lens.org)
-
AMPLICON EXPRESSION VECTOR VACCINESUS20210254078A1 2021-08-19 Pending